CCR7 and myeloid sarcoma: Early MS‐PBMCs exhibited upregulated CCR7+ and interleukin (IL)‐6+ T cells, whereas NFAT1hiT‐bethiCD4+ T and CD141hiIRF8hiCXCR3+CD68− dendritic cells decreased.